ABOUT THE Br.E.A.S.T.
The Br.E.A.S.T. is a cooperative clinical research group initiated by the Chemotherapy Unit of the Jules Bordet Institute, tumor center of the Free University of Brussels (U.L.B.). The fundamental objective of the Br.E.A.S.T. is to design, implement and conduct phase III clinical trials in the field of adjuvant therapy of breast cancer.
Pivotal trials, which are conducted in full adherence with the ICH-GCP and FDA regulations, are ongoing. The group is chaired by Dr Martine Piccart. On the board are also data managers, IT specialists, clinical research associates, data entry operators, medical advisers and secretaries.
The group is an active member of the Breast International Group (B.I.G. - aisbl).
Another aim of Br.E.A.S.T. is the development, implementation and conduct of translational research trials in breast cancer adjuvant therapy, and in particular to identify biological markers with predictive significance in stage I and stage II breast cancer. To this end, Br.E.A.S.T. engages in intensive collaboration with outstanding European laboratories, whose reputations in the field are well-known.
| Address: | Br.E.A.S.T. - Data Center & Operational Office |
|
Institut Jules Bordet Boulevard de Waterloo, 125 1000 Brussels Belgium | |
| E-Mail: | Global information : nadia.santoro@bordet.be |
| Technical information : breast.technical@bordet.be |
|
| Phone number: | (+32) (0)2 541 35 09 |
| Fax number: | (+32) (0)2 541 34 77 |